healthneutral
LDL Goals Missed in Turkish Diabetes Care
TurkeyThursday, May 7, 2026
In 2019, Turkish health authorities tightened the guidelines for low‑density lipoprotein (LDL) cholesterol in people with type‑2 diabetes. The aim was to reduce cardiovascular risk, but a nationwide study shows that most patients still fall short.
Study Overview
- Scope: Multi‑center cohort across Turkey
- Population: Diabetic patients under routine care
- Metric: LDL cholesterol levels compared to 2019 targets
Key Findings
| Metric | Result |
|---|---|
| Proportion meeting LDL goal | < 30 % |
| Median LDL level | 1.8 mmol/L (target < 1.4 mmol/L) |
| Common barriers | Suboptimal medication choice, inadequate dosing, inconsistent follow‑up |
Implications
- Clinical: Stricter targets remain difficult to achieve in everyday practice.
- Public Health: Persistently high LDL may keep cardiovascular events—heart attacks and strokes—in the higher risk bracket for this population.
Recommendations
- Optimize Medication Regimens – consider newer statins or combination therapies where appropriate.
- Standardize Follow‑Up – schedule regular lipid panels and adjust treatment promptly.
- Provider Education – enhance training on guideline interpretation and patient counseling.
Addressing these gaps could bring LDL levels down, potentially reducing the burden of cardiovascular disease among Turkey’s diabetic patients.
Actions
flag content
